• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧自产生纳米平台缓解胰腺癌缺氧并克服声动力治疗抵抗

Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer.

机构信息

Affiliated Tumor Hospital of Guangxi Medical University , 71 He-di Road, Nanning 530021, People's Republic of China.

Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University School of Medicine , 301 Yan-chang-zhong Road, Shanghai 200072, People's Republic of China.

出版信息

ACS Nano. 2017 Dec 26;11(12):12849-12862. doi: 10.1021/acsnano.7b08225. Epub 2017 Dec 15.

DOI:10.1021/acsnano.7b08225
PMID:29236476
Abstract

Hypoxia as one characteristic hallmark of solid tumors has been demonstrated to be involved in cancer metastasis and progression, induce severe resistance to oxygen-dependent therapies, and hamper the transportation of theranostic agents. To address these issues, an oxygen-self-produced sonodynamic therapy (SDT) nanoplatform involving a modified fluorocarbon (FC)-chain-mediated oxygen delivery protocol has been established to realize highly efficient SDT against hypoxic pancreatic cancer. In this nanoplatform, mesopores and FC chains of FC-chain-functionalized hollow mesoporous organosilica nanoparticle carriers can provide sufficient storage capacity and binding sites for sonosensitizers (IR780) and oxygen, respectively. In vitro and in vivo experiments demonstrate the nanoplatform involving this distinctive oxygen delivery protocol indeed breaks the hypoxia-specific transportation barriers, supplies sufficient oxygen to hypoxic PANC-1 cells especially upon exposure to ultrasound irradiation, and relieves hypoxia. Consequently, hypoxia-induced resistance to SDT is inhibited and sufficient highly reactive oxygen species (ROS) are produced to kill PANC-1 cells and shrink hypoxic PANC-1 pancreatic cancer. This distinctive FC-chain-mediated oxygen delivery method provides an avenue to hypoxia oxygenation and holds great potential in mitigating hypoxia-induced resistance to those oxygen-depleted therapies, e.g., photodynamic therapy, radiotherapy, and chemotherapy.

摘要

缺氧作为实体肿瘤的一个特征标志,已被证明参与癌症转移和进展,诱导对氧依赖治疗的严重耐药,并阻碍治疗剂的输送。为了解决这些问题,建立了一种涉及改性氟碳(FC)链介导的氧输送方案的自供氧声动力学治疗(SDT)纳米平台,以实现高效的缺氧胰腺癌 SDT。在该纳米平台中,FC 链功能化的中空介孔有机硅纳米载体的介孔和 FC 链可以分别为声敏剂(IR780)和氧气提供足够的储存容量和结合位点。体外和体内实验表明,该纳米平台确实打破了缺氧特异性运输障碍,在超声辐射暴露下向缺氧 PANC-1 细胞提供足够的氧气,并缓解缺氧。因此,抑制了缺氧诱导的 SDT 耐药性,并产生了足够的高活性氧(ROS)来杀死 PANC-1 细胞并缩小缺氧 PANC-1 胰腺癌。这种独特的 FC 链介导的氧输送方法为缺氧供氧提供了一种途径,并在减轻缺氧诱导的对那些缺氧治疗的耐药性方面具有巨大的潜力,例如光动力疗法、放射疗法和化学疗法。

相似文献

1
Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer.氧自产生纳米平台缓解胰腺癌缺氧并克服声动力治疗抵抗
ACS Nano. 2017 Dec 26;11(12):12849-12862. doi: 10.1021/acsnano.7b08225. Epub 2017 Dec 15.
2
Yttrium oxide nanoparticles induce selective cytotoxicity, genomic instability and ROS mitochondrial P53 mediated apoptosis in human pancreatic cancer cells.氧化钇纳米颗粒在人胰腺癌细胞中诱导选择性细胞毒性、基因组不稳定以及由活性氧线粒体P53介导的细胞凋亡。
Sci Rep. 2025 Jun 20;15(1):20144. doi: 10.1038/s41598-025-05088-9.
3
Construction of Z-Scheme MOF-on-MOF heterostructures for mitochondria-targeted sonodynamic therapy.用于线粒体靶向声动力治疗的Z型MOF-on-MOF异质结构的构建
Acta Biomater. 2025 May 1. doi: 10.1016/j.actbio.2025.05.001.
4
Oxygen-carrying semiconducting polymer nanoprodrugs induce sono-pyroptosis for deep-tissue tumor treatment.载氧半导体聚合物纳米前药诱导声热凋亡用于深部组织肿瘤治疗。
Exploration (Beijing). 2024 Feb 19;4(4):20230100. doi: 10.1002/EXP.20230100. eCollection 2024 Aug.
5
Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer.缺氧缓解纳米平台增强胰腺癌的化疗敏感性和超声动力效应。
Cancer Lett. 2021 Nov 1;520:100-108. doi: 10.1016/j.canlet.2021.07.008. Epub 2021 Jul 8.
6
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
7
A Hypoxia-Triggered Bioreduction of Hydrophilic Type I Photosensitizer for Switchable In Vivo Photoacoustic Imaging and High-Specificity Cancer Phototherapy.一种用于可切换体内光声成像和高特异性癌症光疗的亲水性I型光敏剂的缺氧触发生物还原。
Angew Chem Int Ed Engl. 2025 Jun 17;64(25):e202506412. doi: 10.1002/anie.202506412. Epub 2025 Apr 17.
8
Fluorocarbon-Functionalized Polymerization-Induced Self-Assembly Nanoparticles Alleviate Hypoxia to Enhance Sonodynamic Cancer Therapy.含氟碳官能团的聚合诱导自组装纳米粒子缓解缺氧以增强声动力癌症治疗
Adv Healthc Mater. 2025 Jan;14(2):e2403251. doi: 10.1002/adhm.202403251. Epub 2024 Nov 2.
9
Sonodynamic Therapy and Sonosensitizers for Glioma Treatment: A Systematic Qualitative Review.声动力学疗法与声敏剂在胶质瘤治疗中的应用:系统定性评价。
World Neurosurg. 2023 Oct;178:60-68. doi: 10.1016/j.wneu.2023.07.030. Epub 2023 Jul 15.
10
The safety and efficiency of photodynamic therapy for the treatment of osteosarcoma: A systematic review of in vitro experiment and animal model reports.光动力疗法治疗骨肉瘤的安全性和有效性:体外实验和动物模型报告的系统评价
Photodiagnosis Photodyn Ther. 2022 Dec;40:103093. doi: 10.1016/j.pdpdt.2022.103093. Epub 2022 Aug 27.

引用本文的文献

1
Sonodynamic Therapy-Based DNA Nanocarriers with Hypoxia-Inducible Factor-1α Silencing Activation for Precision Lung Cancer Therapy.基于声动力疗法的DNA纳米载体,具有缺氧诱导因子-1α沉默激活功能,用于精准肺癌治疗。
Biomater Res. 2025 Aug 21;29:0230. doi: 10.34133/bmr.0230. eCollection 2025.
2
Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review.用于胰腺导管腺癌联合治疗的纳米载体:综述
Nanomaterials (Basel). 2025 Jul 22;15(15):1139. doi: 10.3390/nano15151139.
3
Hypoxia-augmented chemotherapy potentiates imaging-guided combinatorial radionuclide-sonodynamic therapy for pancreatic cancer.
缺氧增强化疗可增强成像引导的联合放射性核素-声动力疗法对胰腺癌的治疗效果。
J Nanobiotechnology. 2025 Jul 24;23(1):539. doi: 10.1186/s12951-025-03611-8.
4
Applications of sonodynamic therapy combined with nanobiotechnology in the treatment of digestive tract tumors.声动力疗法联合纳米生物技术在消化道肿瘤治疗中的应用
Discov Oncol. 2025 Jul 1;16(1):1238. doi: 10.1007/s12672-025-02810-x.
5
Prodrug Strategy for PROTACs: High Efficiency and Low Toxicity.PROTACs的前药策略:高效与低毒
ACS Omega. 2025 Jun 5;10(23):23926-23942. doi: 10.1021/acsomega.5c01241. eCollection 2025 Jun 17.
6
A Novel BODIPY-Zn Complex as Innovative Sonosensitizer for Enhanced Sonodynamic Therapy.一种新型BODIPY-Zn配合物作为用于增强声动力治疗的创新型声敏剂
Molecules. 2025 Apr 2;30(7):1587. doi: 10.3390/molecules30071587.
7
Epigenetics disruptions enabled by porphyrin-derived metal-organic frameworks disarm resistances to sonocatalytic ROS anti-tumor actions.卟啉衍生的金属有机框架引发的表观遗传干扰消除了对声催化活性氧抗肿瘤作用的抗性。
Fundam Res. 2022 Jul 25;5(1):296-306. doi: 10.1016/j.fmre.2022.06.020. eCollection 2025 Jan.
8
Acoustically Driven Hybrid Nanocrystals for In Vivo Pancreatic Cancer Treatment.用于体内胰腺癌治疗的声学驱动混合纳米晶体
ACS Appl Mater Interfaces. 2025 Feb 26;17(8):11873-11887. doi: 10.1021/acsami.4c21975. Epub 2025 Feb 17.
9
Piezoelectric Biomaterial with Advanced Design for Tissue Infection Repair.用于组织感染修复的先进设计的压电生物材料。
Adv Sci (Weinh). 2025 Mar;12(10):e2413105. doi: 10.1002/advs.202413105. Epub 2025 Jan 31.
10
Recent Advances and Future Directions in Sonodynamic Therapy for Cancer Treatment.癌症治疗中声动力疗法的最新进展与未来方向
BME Front. 2024 Dec 27;2024:0080. doi: 10.34133/bmef.0080. eCollection 2024.